Quantum Genomics Sa Stock Net Income
| ALQGC Stock | EUR 0.07 0 1.77% |
Quantum Genomics SA fundamentals help investors to digest information that contributes to Quantum Genomics' financial success or failures. It also enables traders to predict the movement of Quantum Stock. The fundamental analysis module provides a way to measure Quantum Genomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Quantum Genomics stock.
Quantum |
Quantum Genomics SA Company Net Income Analysis
Quantum Genomics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Quantum Genomics Net Income | (17.36 M) |
Most of Quantum Genomics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Quantum Genomics SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Quantum Genomics SA reported net income of (17.36 Million). This is 105.09% lower than that of the Biotechnology sector and 124.78% lower than that of the Health Care industry. The net income for all France stocks is 103.04% higher than that of the company.
Quantum Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Quantum Genomics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Quantum Genomics could also be used in its relative valuation, which is a method of valuing Quantum Genomics by comparing valuation metrics of similar companies.Quantum Genomics is currently under evaluation in net income category among its peers.
Quantum Fundamentals
| Return On Equity | -1.23 | |||
| Return On Asset | -0.48 | |||
| Operating Margin | (5.48) % | |||
| Current Valuation | (11.33 M) | |||
| Shares Outstanding | 34.53 M | |||
| Shares Owned By Insiders | 9.18 % | |||
| Shares Owned By Institutions | 3.69 % | |||
| Price To Earning | (5.10) X | |||
| Price To Book | 0.32 X | |||
| Price To Sales | 1.07 X | |||
| Revenue | 116.21 K | |||
| Gross Profit | (12.47 M) | |||
| EBITDA | (18.94 M) | |||
| Net Income | (17.36 M) | |||
| Cash And Equivalents | 5.01 M | |||
| Cash Per Share | 0.89 X | |||
| Total Debt | 283.69 K | |||
| Current Ratio | 3.36 X | |||
| Book Value Per Share | 0.44 X | |||
| Cash Flow From Operations | (17.02 M) | |||
| Earnings Per Share | (0.73) X | |||
| Target Price | 8.8 | |||
| Beta | 0.27 | |||
| Market Capitalization | 5.65 M | |||
| Total Asset | 22.59 M | |||
| Z Score | 11.4 | |||
| Net Asset | 22.59 M |
About Quantum Genomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Quantum Genomics SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quantum Genomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quantum Genomics SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quantum Stock Analysis
When running Quantum Genomics' price analysis, check to measure Quantum Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quantum Genomics is operating at the current time. Most of Quantum Genomics' value examination focuses on studying past and present price action to predict the probability of Quantum Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quantum Genomics' price. Additionally, you may evaluate how the addition of Quantum Genomics to your portfolios can decrease your overall portfolio volatility.